M. Stojanović and D. Bursać, “Immunotoxicity of Pembrolizumab in patients with metastatic non-small cell lung cancer: A single-centre study”, Arch Oncol, vol. 30, no. 1, pp. 14–18, Aug. 2024, doi: 10.2298/AOO240304006S.